Keyword
Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 The Sound of Silence: Claiming Negative Limitations | Kilpatrick Townsend & Stockton LLP JDSupra 1 day ago
2 Novartis beats appeal over MS drug patent, keeping generic at bay Reuters 26 days ago
3 Anti-influenza Drugs Market Analysis, by 2031 | Roche, HEC Pharm, GlaxoSmithKline, Guangzhou Pharmaceutical – The Oxford Spokesman The Oxford Spokesman 2 days ago
4 Silence May Support Negative Claim Limitation | Knobbe Martens JDSupra 24 days ago
5 Erlotinib Hydrochloride Market Scope By 2029 | HEC Pharm, Arasto Pharmaceutical Chemicals Inc., Tava, Polpharma Pharmaceutical Works – The Oxford Spokesman The Oxford Spokesman 3 days ago
6 Liraglutide Market Report SWOT Analysis by 2031 | HEC Pharm, Bachem, Kingpep Biotechnology, Shenzhen JYMed Technology – The Oxford Spokesman The Oxford Spokesman 3 days ago
7 Islet Amyloid Polypeptide Market Report 2022 Market SWOT Analysis,Key Indicators,Forecast 2027 : Adocia SAS, Zealand Pharma AS, Neurimmune Holdin – The Oxford Spokesman The Oxford Spokesman 12 hours ago
8 Sphingosine-1-Receptor Modulators Drugs Market Report 2022 Market SWOT Analysis,Key Indicators,Forecast 2027 : Novartis, HEC Pharm Co. Limited, A – The Oxford Spokesman The Oxford Spokesman 4 days ago
9 Swiss stocks Factors to watch on January 4 26 days ago
10 Rosuvastatin Calcium Market Report 2022 Market SWOT Analysis,Key Indicators,Forecast 2027 : AstraZeneca, Jingxin Pharm, Cadila Pharmaceuticals, T – The Oxford Spokesman The Oxford Spokesman 3 days ago
11 Liver Fibrosis Drug Market Business Dimension Surge Prospects and Development Evaluation up to 2031 Taiwan News 3 days ago
12 Global Entacapone Market 2021 Growth Prospects, Outlook and Product Development to 2027 – The Oxford Spokesman The Oxford Spokesman 2 days ago
13 Morgan Stanley settles personal data breach lawsuit for $60 million The Washington Post 26 days ago
14 Clopidogrel Bisulfate Market Report 2022 Market SWOT Analysis,Key Indicators,Forecast 2027 : Modasa Pharmaceuticals, Yung Zip Chemical, VEEPRHO, – The Oxford Spokesman The Oxford Spokesman 3 days ago
15 Global Liraglutide Market 2021 Introducing New Industry Dynamics Through SWOT Analysis with Leading Players and Forecast 2027 – The Oxford Spokesman The Oxford Spokesman 2 days ago
16 Rosuvastatin Calcium Market Opportunities Assessment along with Detailed Analysis and Forecast 2022-2031 Taiwan News 22 days ago
17 HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity Business Wire 10 months ago
18 Lannett, HEC Pharm Team Up on Insulin Aspart Biosimilar Project The Center for Biosimilars 12 months ago
19 Appalachian Mountain Club names a woman interim CEO BetaBoston 26 days ago
20 Azithromycin Market Report: Production Capacity and Consumption Analysis, Trends Analysis Report and Forecasts, 2022 – 2027 UkrAgroConsult 7 days ago
21 2021 Hepatitis C Pipeline Insights Featuring HEC Pharm, Atea Pharmaceuticals & AllaChem Among Others 10 months ago
22 Blackstone invests $400 million in HEC Pharm via convertible bonds Reuters 3 years ago
23 Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028 FiercePharma 5 months ago
24 HEC allows DPT and Pharm D graduates to use title ‘Dr’ with name The Nation 4 months ago
25 Novartis' Sandoz, with Aubagio generic in its sights, sues FDA to launch copycat first FiercePharma 11 months ago
26 Patent Filings Roundup: IP Edge Files Another 50, Comprising 13% of all District Court Litigation; Hawk Hit with Declaratory Judgment For Asserting Already-Invalid Patent IPWatchdog.com 3 months ago
27 Azithromycin Market and Paracetamol Suppositories Market Demands 2021 Growing Rapidly with Modern Trends, Global Development History, Investment Opportunities, Share Estimation, Sales & Revenue, and Forecast to 2026 | Industry Research Biz Yahoo Finance 5 months ago
28 Novartis Wins Patent Battle for its Blockbuster MS Drug Gilenya BioSpace 1 year ago
29 Novartis announces US District Court for the District of Delaware upholds validity of Gilenya® (fingolimod) dosage regimen patent GlobeNewswire 1 year ago
30 U.S. FDA approves generic versions of Novartis blockbuster MS treatment Reuters 2 years ago
31 Court hands Novartis win in Gilenya patent fight; US states seek $26B+ in opioid crisis lawsuit Endpoints News 1 year ago
32 Biovectra Enhances Manufacturing Capacity and Flexibility with ABEC's CSR® Large-Scale, Single-Use Microbial Fermentation Technology Business Wire 4 months ago
33 FDA greenlights generics of Novartis' $3B MS star Gilenya amid legal fight FiercePharma 2 years ago
34 Cancer mTOR Inhibitors Market Expectation Surges With Rising Demand And Changing Trends by 2031 Taiwan News 4 months ago
35 The Diabetes Market in China Pharmaceutical Executive 4 years ago
36 FDA approves first generics of Gilenya | FDA FDA.gov 2 years ago
37 ABEC CSR® Single-Use Fermenters to Support Catalent Cell & Gene Therapy Manufacturing Expansion Business Wire 10 months ago
38 FDA Approves Three Generic Versions of Novartis' Gilenya for... Multiple Sclerosis News Today 2 years ago
39 ANDA Approvals Spring 2019 | Robins Kaplan LLP 3 years ago
40 mAbxience Expanding Biosimilar and CDMO Manufacturing Capacity with ABEC 4000 Liter Single-Use Bioreactor Business Wire 10 months ago
41 Global Hepatitis B Pipeline Review H2 2020 ResearchAndMarkets.com 1 year ago
42 Lannett And FDA To Meet Over Insulin Glargine Biosimilar Generics Bulletin 2 years ago